Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An Author's Perspective
    • Ask the Experts
    • Bioanalysis articles
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Spotlights
    • Tech Digest
    • T&F journals

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Awareness
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Professional development
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Biosensors
      • Chromatography
      • Flow Cytometry
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register

An interview with Scott Summerfield: Emerging technologies in the bioanalytical field

6 Dec 2017
General interest

For our Spotlight on emerging technologies, we spoke to Scott Summerfield, Worldwide Head of Bioanalysis at GSK (Brentford, UK) about some of the technologies emerging in the bioanalytical field, the advantages and challenges faced with these techniques, and the scope for these technologies to advance further.

Back to our Spotlight – Emerging technologies: DMPK and bioanalysis of small molecules

 

Top content

  • A loaded tip
  • Jessica Bridges Weaver named as a 2026 Women in Business award winner
  • Stretching the limit: new technique improves measurement of cell elasticity

Related tags

emerging technologies interview video
Previous article

Related articles

5 FEB 2020 IMMUNOGENICITY
Jihua Chen on mitigating target interference in bridging immunogenicity assays
29 MAY 2018 LARGE MOLECULES
Top 5 techniques and tips for choosing old vs new technologies
5 OCT 2017 AN AUTHOR'S PERSPECTIVE
An author’s perspective: Gary Van Berkel on immediate drop on demand technology coupled with mass spectrometry
27 JUL 2022 NEWS
The latest sweat accessory: New ‘necklace’ biosensor has the potential to track blood sugar levels through sweat
9 MAR 2020 EXPERT OPINION
Shaping the future of electromembrane extraction
4 MAY 2018 CONFERENCE REPORTS
WRIB 2018 conference report
  • About
  • Accessibility
  • Advertising & Sponsorship
  • Contact Us
  • Editorial Policies
  • Permissions
  • Whitelist Emails
  • Zone Leaders

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Bioanalysis Zone